Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in patients with COVID-19
RBR-85vh8fxPhase 3Completed
- Sponsor
- Vice-Presidência de Pesquisa e Coleções Biológicas
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Favipiravir with Placebo (2 arms). Primary endpoint: Viral clearance. Started May 2022; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-85vh8fx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-85vh8fx.